Secondary placement of shares in Karo Bio (SE) — SEK 96 million Healthcare Secondary placement of shares in Karo Bio (SE) — SEK 96 million
Rights offering in Medivir (SE) — SEK 325 million Healthcare Rights offering in Medivir (SE) — SEK 325 million
Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million Healthcare Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million
Directed new share issue in SAGA Oil ASA (NO) — NOK 180 million Oil & Gas Directed new share issue in SAGA Oil ASA (NO) — NOK 180 million
Secondary offering of shares in Carnegie (SE) — SEK 1.3 billion FIG Secondary offering of shares in Carnegie (SE) — SEK 1.3 billion
New share issue in Axis Biochemicals ASA (NO) — NOK 72 million Healthcare New share issue in Axis Biochemicals ASA (NO) — NOK 72 million
New share issue and IPO in Clavis Pharma ASA (NO) — NOK 242 million Healthcare New share issue and IPO in Clavis Pharma ASA (NO) — NOK 242 million
Directed new share issue in Clavis Pharma ASA (NO) — NOK 154 million Healthcare Directed new share issue in Clavis Pharma ASA (NO) — NOK 154 million
Divestment of Investor’s 14 per cent stake in Global Health Partner AB (SE) Healthcare Divestment of Investor’s 14 per cent stake in Global Health Partner AB (SE)
New share issue in West Siberian Resources Ltd (RU) — SEK 562.5 million Oil & Gas New share issue in West Siberian Resources Ltd (RU) — SEK 562.5 million
Secondary placing of shares in CapMan (FI) — EUR 17.5 million FIG Secondary placing of shares in CapMan (FI) — EUR 17.5 million
Initial public offering and new share issue in NeuroSearch A/S (DK) — DKK 280 million Healthcare Initial public offering and new share issue in NeuroSearch A/S (DK) — DKK 280 million